The accelerating AI infrastructure buildout, along with the ongoing electric vehicle adoption and industrial automation, is ...

Leave it to the Chinese and the mischievous gremlins of the frontier AI modelers like Anthropic and OpenAI, which seem to ...

During Mad Money’s August 6 episode, host Jim Cramer highlighted why investors should target elite advisory firms rather than ...

When a caller asked about IREN Limited (NASDAQ:IREN) during the lightning round of the August 6 episode of Mad Money, Jim ...

Previously, Cramer’s skepticism toward Thomson Reuters Corporation (NASDAQ:TRI) was built on warnings regarding how ...

Intel (NASDAQ:INTC) shares have nearly tripled this year, outrunning AMD (NASDAQ:AMD), Nvidia (NASDAQ:NVDA), and the ...

O Cloudflare (NYSE:NET) announced that Cloudflare for Government achieved FedRAMP High authorization and GovRAMP Moderate ...

As many as three-quarters of S&P 500-member companies have already reported earnings in the second quarter of the year, with ...

Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year ...

For years, investors have viewed Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) through one lens: the race to dominate the ...

The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution.

Sands Capital, an investment management company, released its “Sands Capital Technology Innovators Fund” Q2 2026 investor ...